1 2 Background: Sporadic deletions removing 100s-1000s kb of DNA, and 3 variable numbers of poorly characterised genes, are often found in patients 4 with a wide range of developmental abnormalities. In such cases, 5 understanding the contribution of the deletion to an individual's clinical 6 phenotype is challenging. 7 Methods: Here, as an example of this common phenomenon, we analysed 8 34 patients with simple deletions of ~177 to ~2000 kb affecting one allele of 9 the well characterised, gene dense, distal region of chromosome 16
Introduction
Cytogenetic, molecular genetic, and more recently, next generation sequencing 3 (NGS) approaches have revealed copy number variations (CNVs) in the human 4 genome ranging from 1 to 1000s kb (Iafrate et al., 2004; MacDonald et al., 2014) . 5 CNVs are common in normal individuals and have been identified in ~35% of the 6 human genome (Iafrate et al., 2004) . When present as hemizygous events, in used (Roche NimbleGen, Madison, WI, USA). Array design was based on NCBI 1 Build 36.1 (hg18) and used as previously described (Phylipsen et al., 2012) . 2 Genomic DNA from patients SH(Ju) and SH(Pa) were tested using CytoScan HD 3 arrays (Affymetrix) and analysed using Karyoview software. aCGH was performed 4 with genomic DNA from patients CJ, IM and YA using the Sentrix Human CNV370 5 BeadChip (Illumina) and analysed using GenomeStudio software. 6 7 Whole Genome Sequencing (WGS) 8 WGS was carried out at Edinburgh Genomics, The University of Edinburgh. The 9 pathogenicity of each variant was given a custom deleterious score based on a six-1 0 point scale, (Fu et al., 2013 ) calculated using output from ANNOVAR (Wang et al., 1 1 2010). This was used to prioritise variants present in the hemizygous region of 1 2 chr16p13.3 in each patient and also genome wide. 1 3 Results 1 2 Clinical Features of ATR-16 Syndrome 3 All individuals with ATR-16 syndrome have α -thalassemia because at two of the four 4 paralogous α -globin genes are deleted (--/αα) and this manifests as mild 5 hypochromic microcytic anaemia. In combination with a common small deletion 6 involving one α-gene on the non-paralogous allele (--/-α) patients may have a more 7 severe form of α-thlassaemia referred to as HbH disease (Harteveld & Higgs 2010) . 8 In addition to α -thalassemia, which is always present, common features of ATR-16 9 syndrome include speech delay, developmental delay and a variable degree of facial 1 0 dysmorphism and, in severe cases, abnormalities of the axial skeleton. Newly cloned 1 1 breakpoint sequences are shown in Figure 1 ; deletions are shown in Figure 2 . Deletions larger than 2000 kb including the PKD1 and TSC2 genes lead to severe 1 3 MR with polycystic kidney disease and tuberous sclerosis respectively (European 1 4 Polycystic Kidney Disease Consortium, 1994). 1 5 Eleven patients from 9 families are reported here for the first time (OY, LA, 1 6 TY(MI), TY(Mi), YA, SH(P), SH(Ju), NL, CJ, MY and BAR) and we refine the 1 7 breakpoints in 4 previously reported families (BA, TN, IM, LIN). We define 1 8 breakpoints at the DNA sequence level in 7 of the 13 families studied (Figure 1 ), 6 of 1 9 which have been repaired by the addition of a telomere or subtelomere. In the 2 0
remaining family (SH) the deletion is interstitial and mediated by repeats termed 2 1 short interspersed nuclear elements (SINEs). Identification of Co-Inherited Deleterious Loci 2 4 Three families (LA, YA and TN) have 16p13.3 deletions smaller than 1 Mb Mb may be unmasking deleterious mutations on the intact chromosome 16 allele in 2 7 severely affected patients, we performed whole genome sequencing (WGS) where 2 8 DNA was available (YA and the three affected members of the TN family) and 2 9 considered only coding variants in the hemizygous region of chromosome 16.
0
However, only common variants (allele frequency >5%) were present 3 1 ( Supplementary Table 3 ) suggesting the cause(s) of the relatively severe phenotypes 3 2 in these patients reside elsewhere in the genome. To identity rare variants we 3 3 considered only those absent from the publicly available databases. This analysis 3 4 yielded 14 variants shared between the three affected individuals of family TN 3 5 ( Supplementary Table 4 ). Of these, only one (chr15:64,782,684 G>A) affects a gene 3 6 likely to be involved in the broader ATR16 phenotypic abnormalities. This change 1 leads to a R12X nonsense mutation in SMAD6, a negative regulator of bone Further evidence the effect of ATR-16 deletions is modified by other loci 1 3 comes from patients SH(Ju) and SH(Pa) who harbour the same chromosome 16 1 4 deletion. Patient SH(Pa) has developmental delay and skeletal abnormalities, 1 5 however, his mother SH(Ju) does not have craniofacial nor skeletal abnormalities nor 1 6 developmental delay although she suffers from severe anxiety and depression (see 1 7 Figures 1,2 and Supplementary Information). Genome wide array comparative 1 8 genomic hybridisation (aCGH) analysis revealed that both SH(Ju) and SH(Pa) 1 9 harbour a ~133 kb deletion on the short arm of chromosome 2 including exons 5 to 2 0 13 of NRXN1 ( Supplementary Figure 1) . NRXN1 encodes a cell surface receptor 2 1 involved in the formation of synaptic contacts and has been implicated in autism 2 2 spectrum disorder, facial dysmorphism, anxiety and depression, developmental delay 2 3 and speech delay (e.g. The Autism Genome Project Consortium 2007; Kirov et al., 2 4 2008). This finding offers an explanation for the differences in the phenotypic severity 2 5 of the ATR-16 syndrome affecting these patients as autism differentially affects 2 6 males and females (see Discussion). Chromatin Structure 2 9 Recent reports demonstrate chromosomal rearrangements, including contact frequency is shown for the terminal 2 Mb of chromosome 16 in Figure 2A to 3 3 illustrate the effect of the deletions reported here on the chromatin structure. The 3 4 deletion in BA removes ~50% of the self-interacting domain in which CHTF18, 3 5 RPUSD1, GNG13, and LOC388199 reside thereby potentially removing cis-acting 3 6 regulatory elements of these genes, although the genes themselves remain intact. In Compensatory Gene Expression 9 One explanation for the relatively mild abnormalities in many cases of ATR- 16. This has been described as part of the mechanism of genetic compensation, also 1 3 termed genetic robustness (El-Brolosy and Stainer, 2017). To assay for 1 4 compensatory gene transcription we used qPCR to measure expression of 12 genes 1 5 within the terminal 500 kb of chromosome 16 in lymphoblastoid cells from 20 normal 1 6 individuals and from 10 patients with monosomy for the short-arm of chromosome 16 1 7 and found no evidence of compensatory upregulation: transcripts of all deleted genes 1 8 were present at ~50% of the normal levels in these cells ( Figure 3B ). It is possible 1 9 that other genes in downstream pathways affected by haploinsufficiency may be 2 0
transcriptionally upregulated, however, the mechanisms underlying this are complex 2 1 and beyond the scope of this study. Telomere Position Effect 2 4 Previous work in human cells has shown that telomeres may affect chromatin 2 5 interactions at distances of up to 10 Mb away from the chromosome ends (Robin et 2 6 al, 2014) reducing expression of the intervening genes. This phenomenon, termed 2 7 telomere position effect (TPE) is thought to be mediated by the spreading of 2 8 telomeric heterochromatin to silence nearby genes. In budding yeast this effect can 2 9 extend a few kb towards the sub-telomeres, although in some cases yeast telomeres To determine the effect of telomere proximity on genes adjacent to telomere- 3 3 healed breakpoints we measured their expression relative to the allele present in a 3 4 normal chromosomal context. To achieve this, we screened them for informative 3 5 single nucleotide polymorphisms (SNPs) in EBV transformed lymphoblastoid cells 3 6 generated from ATR-16 patients. The phase of polymorphisms was established 3 7 using mouse erythroleukemia (MEL) cells fused to patient cells and selected to 1 contain a single copy of human chromosome 16, generated as previously described 2 (Zeitlin & Weatherall 1983) . Expressed coding polymorphisms were present in genes 3 whose promoters are <60 kb away from breakpoints in 3 patients: TY, MY and BA. 4 For TY the nearest gene expressed in lymphoblastoid cells containing a 5 coding polymorphism is WDR90, the promoter of which is ~43.1 kb from the 6 abnormally appended telomere ( Figure 3A) . For BA, CHTF18 is the closest 7 expressed polymorphic gene with the promoter ~16.3 kb away from the breakpoint. 8 For MY, CLCN7 is the closest gene expressed in lymphoblastoid cells to contain a 9 polymorphism, the promoter of this gene is ~56.1 kb away from the telomere sequenced amplified fragments containing informative polymorphisms. We compared 1 3 peak heights of polymorphic bases in chromatograms derived from cDNA and 1 4 genomic DNA. None of the alleles assayed in the three patients tested showed any 1 5 evidence of a repressive effect ( Figure 3A ). The deletions in patients reported here range from ~0.177 Mb to ~2 Mb. 9 Previous studies suggest the critical region leading to abnormalities in addition to α-1 0
thalassemia is an 800 kb region between ~0.9 and ~1.7 Mb from the telomere of SOX8 may not lead to MR with complete penetrance and any "critical region" for MR 1 5 starts after this point (Bezerra et al., 2008; Family "F" in Figure 2 ). Supporting this we respectively and show no abnormalities beyond α-thalassemia. 1 8 By contrast, we find LA (deletion ~408 kb) has speech delay and YA (deletion 1 9 ~748 kb), has speech and developmental delay and facial dysmorphism ( Figure 2 ).
Family members of YA also have omphalocele, umbilical hernia and pyloric stenosis 2 1 suggesting there are other loci rendering YA susceptible to developmental 2 2 abnormalities. BA (deletion ~762 kb), who has a similarly sized deletion to YA, has 2 3 developmental delay but no other abnormalities. Four other patients with deletions <1 2 4 Mb (YA, TN(Pa), TN(Pe) and TN(Al)) have speech delay and facial dysmorphism. 2 5 This suggests the risk of developmental and neurological abnormalities arises from 2 6 much smaller terminal chromosome 16 deletions (~400 kb) than previously reported. 2 7 In SH(Pa) we have identified a strong candidate for the discordant 2 8 abnormalities: SH(Pa) also has a deletion of NRXN1, disruptions of which cause 2 9 autism and a range of neurological disorders. There is a higher incidence of autism in 3 0 males than in females, with a ratio of 3.5 or 4.0 to 1 (reviewed in Volkmar et al., 3 1 2004). This phenomenon is also specifically found in individuals with autism resulting 3 2 from rearrangements of NRXN1: Kirov and colleagues (2008) reported two affected 3 3 siblings who inherited a deletion of NRXN1 from their unaffected mother. It is 3 4 therefore possible Sh(Ju) is protected by her gender from the effects of NRXN1 3 5 disruption while the neurological and skeletal abnormalities in Sh(Pa) arise from the 3 6 complex interaction of NRXN1 perturbation with his gender and coinheritance of the present elsewhere in the genome. These may be rare variants (such as those 1 1 identified in the TN and SH families) or common variation; a recent study that shows 1 2 that common genetic variants (allele frequency >5% in the general population) 1 3 contribute 7.7% of the variance of risk to neurodevelopmental disorders (Niemi et al., 1 4 2018), highlighting the complexity of this area. 1 5 Together these observations suggest that monosomy for 16p13.3 unmasks 1 6 the effects of other variants genome-wide. This is supported by findings in SCH who 1 7 has a very similar deletion to BAR and may be more severely affected owing to the 1 8 presence of other CNVs (Scheps et al., 2016) . At the other end of the spectrum, 1 9 large ATR-16 deletions may be associated with relatively mild abnormalities. In LIN abnormalities are very mild and there is no evidence of language delay. Here we 2 3 propose chromosome 16p13.3 deletions larger than 400 kb predispose to MR and 2 4 associated developmental abnormalities, however, we find no evidence for critical 2 5 regions that incrementally worsen ATR-16 syndrome abnormalities. 2 6 We could not detect compensatory up-regulation of the homologues of 2 7 deleted genes. Recently, a case of ATR-16 was reported with a ~948 kb deletion and 2 8 who presented with a neuroblastoma in utero (Quadrifoglio et al., 2016 ). These 2 9 authors speculate that haploinsufficiency of the tumour suppressor AXIN1 may have 3 0
contributed to the neuroblastoma. Our finding that the remaining AXIN1 allele shows 3 1 no compensatory expression supports this hypothesis. 3 2 Terminal chromosome deletions are the most common subtelomeric The presence of high-and low-copy-number repeats at breakpoints may play leading to terminal deletion. Following breakage, chromosomes can acquire a 1 4 telomere by capture or de novo telomere addition, which is thought to be mediated 1 5 by telomerase and this is stimulated by the presence of a telomeric repeat sequence 1 6 to which the RNA subunit of telomerase can bind (reviewed in Hannes et al., 2010). 1 7 We found 5 out of 6 telomere healed events share microhomology with appended 1 8 telomeric sequence. This is the same ratio (5 out of 6 breakpoints with 1 9 microhomology) described by Flint and colleagues and supported by Lamb and 2 0
colleagues (1 out of 1) giving a total 12 out of 13 reported telomere-healed breaks 2 1 characterised on 16p13.3 share microhomology with appended telomere sequences, 2 2 strongly suggesting a role for internal telomerase binding sites (Yang et al., 2011) . It 2 3 may also be that telomerase binding to internal binding sites may inappropriately add 2 4 telomeres and thereby contribute to the generation of the breakpoints. 2 5 The lack of evidence for TPE in silencing gene expression is surprising and at 2 6 variance with previous findings (Stadler et al., 2013) , which show that TPE can 2 7 influence gene expression at least 80 kb from the start of telomeric repeats. 2 8 However, TPE is likely to be context and cell type dependent. Additionally, because 2 9 of the lack of informative expressed polymorphisms in the patients studied here it was not possible for us to assay expression of genes immediately adjacent to 3 1 telomeres and a more comprehensive screen may reveal TPE mediated gene 3 2 silencing closer to the telomere. Additionally, when the area of chromatin interaction (visualised by HiC) is considered (Figure 2 ), contact domains for many genes 3 4 adjacent to chromosomal breaks are severely disrupted. This is likely to include the 3 5 loss of cis-acting regulatory elements and may bring the genes under the control of 3 6 illegitimate regulatory elements (Franke et al., 2016) . Therefore, it is likely that genes 1 adjacent to breakpoints would be incorrectly spatiotemporally expressed. 2 This work substantially increases the number of fully characterised cases of 3 ATR-16 syndrome reported and provides a uniquely well characterised model for 4 understanding how sporadic deletions giving rise to extended regions of monosomy 5 may affect phenotype. The findings show larger deletions have a greater impact but 6 importantly our analysis suggests there is no critical region defining the degree of 7 phenotypic abnormalities this has important implications for genetic counselling. 8 Analysis of patients with uncomplicated deletions also revealed unexpected 9 background genetic effects that alter phenotypic severity of CNVs. Acknowledgements: 1 3 The authors thank Markissia Karagiorga-Lagana, MD, ex Director, Thalassaemia 1 4 Unit, "Aghia Sophia" Childrens Hosital Athens Greece for referring case BAR. This (MC_uu_12009). 
